ReviewCancer cell international2026
The pro-metastatic role of microbiota in tumors: a comprehensive review.
Review in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cancer metastasis remains a major obstacle in oncology and significantly worsens patient outcomes. A key challenge lies in understanding when and how tumor cells overcome biological barriers to spread, and to what extent external or internal factors modulate this process. Among these, the human microbiota-comprising trillions of microbes vastly outnumbering human cells-has emerged as a crucial regulator of both health and disease. Recent studies have identified the presence of microbiotas within tumor tissues; these microbes, together with other stromal elements, shape the tumor microenvironment (TME) and critically influence cancer progression and metastasis. Notably, intratumor microbiotas have been implicated in altering local immune responses, inducing DNA damage, and reprogramming cancer-associated pathways. These groundbreaking findings have expanded our understanding of tumor biology and offer promising therapeutic avenues. In this review, we aim to comprehensively summarize current evidence on how intratumor microbes contribute to tumor progression and metastasis. We further highlight how modulation of these microbes may serve as a novel anticancer strategy. We also discuss gaps in the literature and propose future research directions that can bridge the bench-to-bedside translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.